In 2018, Curtis Oltmans earned a total compensation of $4M as General Counsel at Array BioPharma.
|Ranking||2,333 out of 11,002|
Curtis Oltmans' 2018 compensation ranked 2,333rd out of 11,002 executive pay records tracked by us this year.
Oltmans earned more than 78.8% of all executives tracked by us in 2018.
|Ranking||235 out of 1,265|
In the industry group of Drugs, Oltmans' pay ranked 235th out of 1,265 executive pay records tracked by us in 2018.
Oltmans earned more than 81.4% of executives in this group.
|Non-Equity Incentive Plan||$154,604|
Oltmans received $3M in option awards, which accounts for 75.12% of total compensation.
Oltmans also received $5K in bonus, $154.6K in non-equity incentive plan, $351.5K in salary, $305.8K in stock awards and $171.9K in other compensation.